SCHEMBL22047375

SCHEMBL22047375

CCOC(=O)C(CCC#N)(CCC#N)C(=O)Oc1ccc(F)cc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.64
KMT2A Q03164 3/20 0.64
MAPT P10636 4/20 0.40
ALDH1A1 P00352 2/20 0.40
SMN1; SMN2 Q16637 3/20 0.38
L3MBTL1 Q9Y468 2/20 0.38
HPGD P15428 1/20 0.36
MAPK1 P28482 1/20 0.36
CYP1A2 P05177 2/20 0.36
NPSR1 Q6W5P4 2/20 0.36
LMNA P02545 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
CACNA1G O43497 1/20 0.36
THRB P10828 1/20 0.36
ALOX12 P18054 1/20 0.36
NMT2 O60551 1/20 0.35
NMT1 P30419 1/20 0.35
ATM Q13315 1/20 0.35
ELANE P08246 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21850141 0.87 KMT2A (0.44) MEN1KMT2AMAPTALDH1A1SMN1; SMN2
SCHEMBL155369 0.82 MEN1 (0.53) MEN1KMT2AALDH1A1SMN1; SMN2L3MBTL1
SCHEMBL1341844 0.80 MEN1 (1.00) MEN1KMT2AMAPTALDH1A1SMN1; SMN2
SCHEMBL2309108 0.77 KMT2A (0.53) MEN1KMT2AMAPTALDH1A1SMN1; SMN2
SCHEMBL21850140 0.76 KMT2A (0.49) MEN1KMT2AMAPTL3MBTL1HPGD
SCHEMBL1343741 0.76 MEN1 (0.89) MEN1KMT2AMAPTALDH1A1SMN1; SMN2
SCHEMBL3653375 0.74 MEN1 (0.86) MEN1KMT2AMAPTALDH1A1SMN1; SMN2
SCHEMBL25555697 0.74 MEN1 (0.86) MEN1KMT2AMAPTALDH1A1SMN1; SMN2
SCHEMBL8979177 0.73 MEN1 (0.83) MEN1KMT2AMAPTALDH1A1SMN1; SMN2
SCHEMBL1788818 0.69 KMT2A (0.49) MEN1KMT2AMAPTALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200176817-A1 ELECTROLYTE AND BATTERY CONTEMPORARY AMPEREX TECHNOLOGY (HONG KONG) LIMITED (CN) 2020-06-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200176817-A1 ELECTROLYTE AND BATTERY ANO1, KCNN2, HCN2 MEN1 837/4885KMT2A 2566/4885MAPT 3114/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.